Exelixis Clinical Site #38

Paris 75020

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Metastatic Prostate Cancer, Prostate Adenocarcinoma

Studies at this site

• Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer — Running, not enrolling
• Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC — Running, not enrolling